Moving beyond the topic, Companion Diagnostics in Targeted Treatment, the panel took on the unregulated nature of testing in the wake of the June 2013 US Supreme Court ruling against Myriad Genetics, which ended the company's BRCA testing monopoly.
Michael A. Kolodziej, MD
Advertisement
Articles by Michael A. Kolodziej, MD
A lively discussion on Foundation Medicine's approach to creating genomic profiles.
Advertisement
Latest Updated Articles
- Next-Generation Sequencing in Oncology: Are We Ready for Prime Time?
January 29th 2014
Advertisement
Advertisement
Trending on AJMC
1
Patient Portal Messages Outpace Office Visits
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5